Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kory I. Fleming"'
Autor:
Christopher J. Pannucci, MD, MS, Kory I. Fleming, MPH, Corinne Bertolaccini, PharmD, Ann Marie Prazak, PharmD, BCPS, Gregory J. Stoddard, MPH, Arash Momeni, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 7, Iss 4, p e2185 (2019)
Venous thromboembolism is an important patient safety in plastic surgery, and multiple clinical trials in the past 10 years have provided increased understanding of the risks and benefits of venous thromboembolism prevention strategies. This paper pr
Externí odkaz:
https://doaj.org/article/12b046dc55734e8596b44c2c1cb69d19
Autor:
Christopher J. Pannucci, MD MS, Kory I. Fleming, MPH, Ann Marie Prazak, PharmD, Jayant Agarwal, MD, W. Bradford Rockwell, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 5, Iss 9S, Pp 164-165 (2017)
Externí odkaz:
https://doaj.org/article/871bf7e0cdcf46b0aa4c5d16b4eb50eb
Autor:
John R. Stringham, Lyen C. Huang, Arash Momeni, Christopher J. Pannucci, Thomas K. Varghese, Kory I. Fleming, Corinne Bertolaccini, T Bartley Pickron, Ann Marie Prazak
Publikováno v:
Ann Surg
Objective To examine the relationship between enoxaparin dose adequacy, quantified with anti-Factor Xa (aFXa) levels, and 90-day symptomatic venous thromboembolism (VTE) and post-operative bleeding. Summary background data Surgical patients often dev
Autor:
W. Bradford Rockwell, Shaun D. Mendenhall, Christopher J. Pannucci, Jayant P. Agarwal, Arash Momeni, Isak A. Goodwin, Alvin C. Kwok, Barbu Gociman, Kory I. Fleming, Corinne Bertolaccini
Publikováno v:
Plastic and reconstructive surgery. 147(4)
The accepted "one-size-fits-all" dose strategy for prophylactic enoxaparin may not optimize the medication's risks and benefits after surgical procedures. The authors hypothesized that weight-based administration might improve the pharmacokinetics of
Autor:
Nick W. Lonardo, Ram Nirula, Christopher J. Pannucci, Joseph E. Tonna, Kory I. Fleming, Jade Nunez, Vanessa Wall, R. Wayne Shipley
Publikováno v:
The American Journal of Surgery. 216:222-229
The purpose of this study was to determine if fixed dose enoxaparin prophylaxis provided effective anticoagulation for acute care surgery patients and to examine whether a real-time enoxaparin dose adjustment algorithm optimized anticoagulation.Acute
Autor:
Kory I. Fleming, Christopher J. Pannucci, Arash Momeni, Jayant P. Agarwal, Ann Marie Prazak, W. Bradford Rockwell
Publikováno v:
Plastic and Reconstructive Surgery. 142:239-249
Background Venous thromboembolism is a life- or limb-threatening complication that occurs in plastic surgery patients. At present, the optimal dose of enoxaparin that balances the risk of venous thromboembolism and the risk of medication-related adve
Publikováno v:
Journal of Vascular Surgery: Venous and Lymphatic Disorders. 6:304-311
Perioperative venous thromboembolism (VTE) risk can be quantified with the 2005 Caprini score. The Caprini score has previously been validated by review of the electronic medical record (EMR) in3000 plastic surgery patients. However, the accuracy of
Publikováno v:
Plastic and Reconstructive Surgery. 140:815-822
Background Surgeons commonly provide enoxaparin prophylaxis to high-risk patients to decrease venous thromboembolism risk. The authors' prior work demonstrated that most patients receive inadequate venous thromboembolism prophylaxis, based on anti-fa
Autor:
William A. Jones, Daniel L Jones, Thomas F. Higgins, Christopher J. Pannucci, Yingying Zhang, Kory I. Fleming, David L. Rothberg
Publikováno v:
Journal of orthopaedic trauma. 33(11)
To determine the feasibility and impact of real-time anti-factor Xa (aFXa) level monitoring and enoxaparin dose adjustment in orthopaedic trauma. To examine the adequacy of standard fixed-dose enoxaparin chemoprophylaxis and to examine whether patien
Autor:
Corinne Bertolaccini, Kory I. Fleming, Christopher J. Pannucci, Shari Barnett, Thomas K. Varghese, John R. Stringham, Jules Lin, Lauren Moulton
Publikováno v:
The Annals of thoracic surgery. 109(6)
Background Venous thromboembolism is an important patient safety issue in thoracic surgery patients. The optimal enoxaparin dose remains unclear. This multicenter pre/post clinical trial compared the pharmacokinetics of fixed versus weight-tiered eno